Inventor · disambiguated record
Jing Su
Also filed as: SU JING
39 granted patents·26 pending applications·293 citations·filing 1999–2025
97Inventor score
Files withMERCK SHARP & DOHME11MERCK SHARP & DOHME LLC9SCHERING CORP9NOVO NORDISK AS5BENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD4
Top patents by PatentIndex Score
65 records- 0194US9422368B2Humanized anti-human NKG2A monoclonal antibodyNOVO NORDISK AS·Filed 2014·Granted Aug 23, 2016·62 cites·1 claims
- 0292US10758625B2Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereofBENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD·Filed 2016·Granted Sep 1, 2020·12 cites·6 claims
- 0391US8796427B2Humanized anti-human NKG2A monoclonal antibodySPEE PETRUS JOHANNES LOUIS·Filed 2009·Granted Aug 5, 2014·45 cites·6 claims
- 0490US10947205B2Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2019·Granted Mar 16, 2021·5 cites·11 claims
- 0588US6225329B1Modulators of protein tyrosine phosphatases (PTPases)NOVO NORDISK AS·Filed 1999·Granted May 1, 2001·58 cites·13 claims
- 0687US11105818B2MIC-1 receptor and uses thereofNOVO NORDISK AS·Filed 2017·Granted Aug 31, 2021·3 cites·3 claims
- 0787US11000603B2Multi-specific binding conjugate, related pharmaceutical compositions and useBENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD·Filed 2018·Granted May 11, 2021·4 cites·9 claims
- 0886US9708336B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 18, 2017·4 cites·26 claims
- 0985US9839642B2Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Dec 12, 2017·3 cites·19 claims
- 1085US7045636B2MCH antagonists for the treatment of obesitySCHERING CORP·Filed 2002·Granted May 16, 2006·35 cites·21 claims
- 1184US8535909B2E. coli BL21 strain lacking a functional group II capsular gene clusterWOELDIKE HELLE FABRICIUS·Filed 2009·Granted Sep 17, 2013·12 cites·14 claims
- 1282US6472394B1MCH antagonists and their use in the treatment of obesitySCHERING CORP·Filed 2001·Granted Oct 29, 2002·24 cites·12 claims
- 1380US8067621B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsASBEROM THEODROS·Filed 2007·Granted Nov 29, 2011·5 cites·48 claims
- 1479US7723342B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2006·Granted May 25, 2010·4 cites·61 claims
- 1577US7592419B2Macrocyclic inhibitors of hepatitis C virus NS3-serine proteaseSCHERING CORP·Filed 2004·Granted Sep 22, 2009·11 cites·36 claims
- 1674US9034829B1pH-sensitive polymer-drug conjugates for targeted delivery of therapeuticsUNIV NORTHWESTERN·Filed 2012·Granted May 19, 2015·1 cites·5 claims
- 1772US9012594B2Catalyst and byproduct-free native chemical ligation using cyclic thioester precursorsMESSERSMITH PHILLIP B·Filed 2011·Granted Apr 21, 2015·1 cites·22 claims
- 1871US8569521B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsASBEROM THEODROS·Filed 2011·Granted Oct 29, 2013·2 cites·64 claims
- 1970US8426566B2Basic protein purification tags from thermophilic bacteriaSHAW ALLAN CHRISTIAN·Filed 2011·Granted Apr 23, 2013·1 cites·13 claims
- 2069US12077591B2TrkA antibody and application thereof4B TECH SUZHOU LIMITED·Filed 2023·Granted Sep 3, 2024·0 cites·14 claims
- 2168US2024425605A1TrkA ANTIBODY AND APPLICATION THEREOF4B TECH SUZHOU LIMITED·Filed 2024·Application pending·0 cites
- 2266US11752128B2Benzimidazoles and indoles as taro inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Sep 12, 2023·0 cites·3 claims
- 2365US2025154173A1Ripk1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 2464US2021061777A1Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 2564US2024228535A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2663US11738010B2Oxazolidinones as TarO inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Aug 29, 2023·0 cites·14 claims
- 2762US7504391B2Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disordersSCHERING CORP·Filed 2004·Granted Mar 17, 2009·1 cites·26 claims
- 2861US11932637B2Chromane amidine monobactam compounds for the treatment of bacterial infectionsMERCK SHARP & DOHME LLC·Filed 2022·Granted Mar 19, 2024·0 cites·49 claims
- 2961US2020345854A1Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereofBENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD·Filed 2020·Application pending·0 cites
- 3060US2021338836A1Multi-specific binding conjugate, related pharmaceutical compositions and useBENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD·Filed 2021·Application pending·0 cites
- 3159US11141410B2Oxazolidinones as taro inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 12, 2021·0 cites·14 claims
- 3259US2025171447A1Adenosine receptor antagonists, pharmaceutical compositions and their use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3359US2025223259A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3457US12180226B2Spirotricycle RIPK1 inhibitors and methods of uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 31, 2024·0 cites·27 claims
- 3557US11141403B2Benzimidazoles and indoles as taro inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 12, 2021·0 cites·1 claims
- 3656US8841408B2Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparationMESSERSMITH PHILLIP B·Filed 2008·Granted Sep 23, 2014·0 cites·11 claims
- 3756US2024208986A1Phenyl azepines as ripk1 inhibitors and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3856US2025388534A1Supramolecular tranexamic acid-mandelic acid ionic salt as well as preparation method therefor and use thereofSHENZHEN SHINEHIGH INNOVATION CO LTD·Filed 2025·Application pending·0 cites
- 3956US2024228506A1Ripk1 inhibitors and methods of useDIMAURO ERIN F·Filed 2022·Application pending·0 cites
- 4055US10144741B2Nargenicin compounds and uses thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2018·Granted Dec 4, 2018·0 cites·13 claims
- 4154US8420626B2Arene connected polyamine macrocyclic derivatives, preparation methods and pharmaceutical uses thereofLI SONG·Filed 2008·Granted Apr 16, 2013·0 cites·7 claims
- 4254US8137929B2Basic protein purification tags from thermophilic bacteriaSHAW ALLAN CHRISTIAN·Filed 2006·Granted Mar 20, 2012·0 cites·12 claims
- 4354US2014206570A1Characterization of biochips containing self-assembled monolayersMRKSICH MILAN·Filed 2014·Application pending·0 cites
- 4453US9636374B2pH-sensitive polymer-drug conjugates for targeted delivery of therapeuticsUNIV NORTHWESTERN·Filed 2015·Granted May 2, 2017·0 cites·16 claims
- 4553US2014134642A1Characterization of biochips containing self-assembled monolayersMRKSICH MILAN·Filed 2014·Application pending·0 cites
- 4653US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 4752US9944654B2Nargenicin compounds and uses thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2015·Granted Apr 17, 2018·0 cites·15 claims
- 4852US2025230159A1Fused heterocyclic compounds as modulators of ras signallingSHENZHEN IONOVA LIFE SCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 4951US10752621B2Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2018·Granted Aug 25, 2020·0 cites·16 claims
- 5050US2006138083A1Patterning and alteration of moleculesRYAN DECLAN·Filed 2005·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jing Su files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →